Disitamab Vedotin (RC48): clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
6
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 2
Conditions being studied
| Condition | Trials |
|---|---|
| Breast Cancer | 2 |
| Advanced Breast Cancer | 1 |
| HER2 + Breast Cancer | 1 |
| HER2-negative Breast Cancer | 1 |
| Metastatic Breast Cancer | 1 |
| Triple Negative Breast Cancer (TNBC) | 1 |
Recruiting trials involving Disitamab Vedotin (RC48)
- Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
- RC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II Study
Common questions
How many recruiting trials involve Disitamab Vedotin (RC48)?
2 recruiting trials across 6 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.